● The company usually posts poor financials for mid or long term investments.
● For a short-term investment strategy, the company has poor fundamentals.
● According to forecast, a sluggish sales growth is expected for the next fiscal years.
● The company does not generate enough profits, which is an alarming weak point.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
● With an expected P/E ratio at 59.53 and 11.21 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
● For the past seven days, analysts have been lowering their EPS expectations for the company.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.